Jubilant Pharmova Ltd
JUBLPHARMA
Pharmaceuticals
₹ 1,155
Price
₹ 18,401
Market Cap
Mid Cap
33.16
P/E Ratio
📊 Score Snapshot
13.71 / 25
Performance
25 / 25
Valuation
2.47 / 20
Growth
7.0 / 30
Profitability
48.18 / 100
Risky
🏢 Company Overview
⏳ Loading company overview...
🤖 CARL Insights
⏳ Loading CARL insights...
📈 Net Profit (Yearly)
📊 Sales (Yearly)
📉 Quarterly Sales Trend
📉 Quarterly Net Profit
📈 Yearly Ratios
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| Adj Cash EBITDA | 1,342 | 1,247 | 884.00 | 983.00 | 1,683 | 1,626 | 1,479 | 1,577 |
| Adj Cash EBITDA Margin | 18.49 | 18.47 | 13.99 | 16.23 | 28.12 | 26.24 | 16.61 | 21.37 |
| Adj Cash EBITDA To EBITDA | 1.09 | 1.25 | 1.07 | 0.85 | 1.17 | 0.90 | 0.83 | 1.01 |
| Adj Cash EPS | 79.01 | 16.18 | 8.30 | 14.68 | 79.01 | 43.59 | 5.72 | 41.03 |
| Adj Cash PAT | 1,255 | 253.43 | 128.28 | 233.03 | 1,259 | 693.97 | 94.08 | 645.05 |
| Adj Cash PAT To PAT | 1.10 | 589.37 | 1.73 | 0.57 | 1.25 | 0.79 | 0.24 | 1.02 |
| Adj Cash PE | 14.99 | 46.29 | - | 27.79 | 8.88 | 5.29 | 39.21 | 17.93 |
| Adj EPS | 71.97 | 0.28 | 4.91 | 25.85 | 63.32 | 54.90 | 24.63 | 40.15 |
| Adj EV To Cash EBITDA | 12.08 | 10.37 | 7.76 | 8.65 | 7.89 | 4.39 | 9.06 | 9.37 |
| Adj EV To EBITDA | 13.18 | 13.01 | 8.27 | 7.32 | 9.27 | 3.95 | 7.53 | 9.45 |
| Adj Number Of Shares | 15.92 | 15.91 | 15.93 | 15.94 | 15.93 | 15.92 | 15.92 | 15.94 |
| Adj PE | 16.94 | - | - | 15.81 | 11.04 | 4.23 | 18.02 | 18.33 |
| Adj Peg | - | - | - | - | 0.72 | 0.03 | - | 1.52 |
| Bvps | 391.90 | 340.73 | 338.42 | 333.56 | 297.68 | 352.01 | 302.07 | 253.14 |
| Cash Conversion Cycle | 65.00 | 124.00 | 165.00 | 224.00 | 194.00 | 268.00 | 92.00 | 87.00 |
| Cash ROCE | 1.14 | 0.11 | -9.42 | 1.48 | 9.84 | 6.59 | 3.75 | 10.61 |
| Cash Roic | 0.69 | -0.37 | -8.49 | 1.44 | 9.88 | 4.86 | 3.41 | 9.55 |
| Cash Revenue | 7,258 | 6,752 | 6,321 | 6,058 | 5,986 | 6,196 | 8,906 | 7,378 |
| Cash Revenue To Revenue | 1.00 | 1.01 | 1.01 | 0.99 | 0.98 | 1.04 | 0.98 | 0.98 |
| Dio | 178.00 | 220.00 | 268.00 | 308.00 | 268.00 | 463.00 | 147.00 | 177.00 |
| Dpo | 158.00 | 146.00 | 160.00 | 139.00 | 124.00 | 273.00 | 106.00 | 145.00 |
| Dso | 45.00 | 50.00 | 56.00 | 55.00 | 49.00 | 79.00 | 51.00 | 55.00 |
| Dividend Yield | 0.52 | 0.77 | 1.78 | 1.20 | 0.74 | 2.13 | 0.69 | 0.39 |
| EV | 16,213 | 12,929 | 6,860 | 8,502 | 13,278 | 7,137 | 13,396 | 14,769 |
| EV To EBITDA | 18.64 | 11.12 | 7.71 | 7.30 | 11.07 | 3.88 | 6.49 | 9.43 |
| EV To Fcff | 299.29 | - | - | 76.25 | 15.38 | 15.10 | 44.89 | 19.36 |
| Fcfe | -561.21 | -273.57 | 119.28 | 261.03 | -256.33 | -31.03 | 478.08 | -51.95 |
| Fcfe Margin | -7.73 | -4.05 | 1.89 | 4.31 | -4.28 | -0.50 | 5.37 | -0.70 |
| Fcfe To Adj PAT | -0.49 | -636.21 | 1.61 | 0.64 | -0.25 | -0.04 | 1.21 | -0.08 |
| Fcff | 54.17 | -30.14 | -709.31 | 111.50 | 863.48 | 472.79 | 298.39 | 762.81 |
| Fcff Margin | 0.75 | -0.45 | -11.22 | 1.84 | 14.42 | 7.63 | 3.35 | 10.34 |
| Fcff To NOPAT | 0.08 | -0.14 | 1.36 | 0.22 | 1.11 | 0.54 | 0.34 | 0.93 |
| Market Cap | 14,599 | 10,251 | 4,445 | 6,531 | 11,360 | 3,798 | 10,041 | 11,621 |
| PB | 2.34 | 1.89 | 0.82 | 1.23 | 2.40 | 0.68 | 2.09 | 2.88 |
| PE | 17.40 | 133.12 | - | 15.77 | 13.59 | 4.23 | 17.49 | 18.07 |
| Peg | 0.02 | - | - | - | - | 0.08 | - | 1.55 |
| PS | 2.02 | 1.53 | 0.71 | 1.07 | 1.86 | 0.64 | 1.10 | 1.55 |
| ROCE | 8.13 | 2.90 | -7.29 | 6.35 | 8.90 | 10.64 | 10.49 | 11.34 |
| ROE | 19.60 | 0.01 | 1.39 | 8.17 | 19.50 | 16.79 | 8.93 | 17.00 |
| Roic | 8.73 | 2.70 | -6.25 | 6.51 | 8.90 | 9.04 | 10.01 | 10.23 |
| Share Price | 917.00 | 644.30 | 279.05 | 409.70 | 713.15 | 238.59 | 630.71 | 729.07 |
📊 Quarterly Results
| Metric | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,929 | 1,822 | 1,752 | 1,732 | 1,759 | 1,677 | 1,680 | 1,587 | 1,678 | 1,552 | 1,600 | 1,452 | 1,528 | 1,311 |
| Interest | 53.00 | 56.00 | 61.00 | 71.00 | 73.00 | 71.00 | 66.00 | 62.00 | 56.00 | 51.00 | 42.00 | 40.00 | 40.00 | 37.00 |
| Expenses - | 1,584 | 1,535 | 1,463 | 1,480 | 1,487 | 1,459 | 1,438 | 1,419 | 1,459 | 1,408 | 1,384 | 1,259 | 1,280 | 1,116 |
| Other Income - | 11.90 | 9.20 | 21.70 | 14.00 | 17.80 | 48.90 | 18.90 | 8.60 | 21.20 | 9.50 | 13.10 | 11.30 | -1.62 | 5.94 |
| Exceptional Items | -3.30 | -18.90 | -14.20 | 395.90 | -168.90 | - | - | - | - | - | -56.80 | - | - | - |
| Depreciation | 95.00 | 91.00 | 91.00 | 91.00 | 101.00 | 95.00 | 97.00 | 90.00 | 271.00 | 94.00 | 94.00 | 95.00 | 101.00 | 93.00 |
| Profit Before Tax | 206.00 | 130.00 | 144.00 | 500.00 | -54.00 | 101.00 | 98.00 | 25.00 | -86.00 | 9.00 | 36.00 | 69.00 | 106.00 | 70.00 |
| Tax % | 26.70 | 22.31 | 29.17 | 3.60 | -14.81 | 34.65 | 36.73 | 76.00 | -16.28 | 277.78 | 86.11 | 31.88 | 44.34 | 27.14 |
| Net Profit - | 151.00 | 101.00 | 102.00 | 482.00 | -62.00 | 66.00 | 62.00 | 6.00 | -100.00 | -16.00 | 5.00 | 47.00 | 59.00 | 51.00 |
| Minority Share | 2.00 | - | - | - | 3.00 | - | - | - | 3.00 | - | - | - | - | - |
| Exceptional Items At | -1.00 | -14.00 | -10.00 | 375.00 | -61.00 | - | - | - | - | - | 36.00 | - | - | - |
| Profit For PE | 153.00 | 115.00 | 113.00 | 107.00 | -1.00 | 66.00 | 62.00 | 6.00 | -98.00 | -16.00 | -31.00 | 47.00 | 59.00 | 51.00 |
| Profit For EPS | 154.00 | 101.00 | 103.00 | 482.00 | -59.00 | 67.00 | 62.00 | 6.00 | -98.00 | -16.00 | 5.00 | 47.00 | 60.00 | 51.00 |
| EPS In Rs | 9.64 | 6.33 | 6.45 | 30.26 | -3.68 | 4.19 | 3.92 | 0.40 | -6.15 | -0.98 | 0.34 | 2.96 | 3.74 | 3.20 |
| PAT Margin % | 7.83 | 5.54 | 5.82 | 27.83 | -3.52 | 3.94 | 3.69 | 0.38 | -5.96 | -1.03 | 0.31 | 3.24 | 3.86 | 3.89 |
| PBT Margin | 10.68 | 7.14 | 8.22 | 28.87 | -3.07 | 6.02 | 5.83 | 1.58 | -5.13 | 0.58 | 2.25 | 4.75 | 6.94 | 5.34 |
| Tax | 55.00 | 29.00 | 42.00 | 18.00 | 8.00 | 35.00 | 36.00 | 19.00 | 14.00 | 25.00 | 31.00 | 22.00 | 47.00 | 19.00 |
| Yoy Profit Growth % | 16,210 | 73.00 | 81.00 | 1,676 | 99.00 | 526.00 | 301.00 | -87.00 | -266.00 | -131.00 | -122.00 | -71.00 | -73.00 | -84.00 |
| Adj Ebit | 261.90 | 205.20 | 219.70 | 175.00 | 188.80 | 171.90 | 163.90 | 86.60 | -30.80 | 59.50 | 135.10 | 109.30 | 145.38 | 107.94 |
| Adj EBITDA | 356.90 | 296.20 | 310.70 | 266.00 | 289.80 | 266.90 | 260.90 | 176.60 | 240.20 | 153.50 | 229.10 | 204.30 | 246.38 | 200.94 |
| Adj EBITDA Margin | 18.50 | 16.26 | 17.73 | 15.36 | 16.48 | 15.92 | 15.53 | 11.13 | 14.31 | 9.89 | 14.32 | 14.07 | 16.12 | 15.33 |
| Adj Ebit Margin | 13.58 | 11.26 | 12.54 | 10.10 | 10.73 | 10.25 | 9.76 | 5.46 | -1.84 | 3.83 | 8.44 | 7.53 | 9.51 | 8.23 |
| Adj PAT | 148.58 | 86.32 | 91.94 | 863.65 | -255.91 | 66.00 | 62.00 | 6.00 | -100.00 | -16.00 | -2.89 | 47.00 | 59.00 | 51.00 |
| Adj PAT Margin | 7.70 | 4.74 | 5.25 | 49.86 | -14.55 | 3.94 | 3.69 | 0.38 | -5.96 | -1.03 | -0.18 | 3.24 | 3.86 | 3.89 |
| Ebit | 265.20 | 224.10 | 233.90 | -220.90 | 357.70 | 171.90 | 163.90 | 86.60 | -30.80 | 59.50 | 191.90 | 109.30 | 145.38 | 107.94 |
| EBITDA | 360.20 | 315.10 | 324.90 | -129.90 | 458.70 | 266.90 | 260.90 | 176.60 | 240.20 | 153.50 | 285.90 | 204.30 | 246.38 | 200.94 |
| EBITDA Margin | 18.67 | 17.29 | 18.54 | -7.50 | 26.08 | 15.92 | 15.53 | 11.13 | 14.31 | 9.89 | 17.87 | 14.07 | 16.12 | 15.33 |
| Ebit Margin | 13.75 | 12.30 | 13.35 | -12.75 | 20.34 | 10.25 | 9.76 | 5.46 | -1.84 | 3.83 | 11.99 | 7.53 | 9.51 | 8.23 |
| NOPAT | 183.25 | 152.27 | 140.24 | 155.20 | 196.33 | 80.38 | 91.74 | 18.72 | -60.47 | -88.89 | 16.95 | 66.76 | 81.82 | 74.32 |
| NOPAT Margin | 9.50 | 8.36 | 8.00 | 8.96 | 11.16 | 4.79 | 5.46 | 1.18 | -3.60 | -5.73 | 1.06 | 4.60 | 5.35 | 5.67 |
| Operating Profit | 250.00 | 196.00 | 198.00 | 161.00 | 171.00 | 123.00 | 145.00 | 78.00 | -52.00 | 50.00 | 122.00 | 98.00 | 147.00 | 102.00 |
| Operating Profit Margin | 12.96 | 10.76 | 11.30 | 9.30 | 9.72 | 7.33 | 8.63 | 4.91 | -3.10 | 3.22 | 7.62 | 6.75 | 9.62 | 7.78 |
💰 Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7,234 | 6,703 | 6,282 | 6,130 | 6,099 | 5,976 | 9,111 | 7,518 | 5,861 | 5,749 | 5,751 | 5,762 |
| Interest | 240.00 | 272.00 | 188.00 | 145.00 | 184.00 | 200.00 | 220.00 | 284.00 | 341.00 | 371.00 | 368.00 | 337.00 |
| Expenses - | 6,061 | 5,802 | 5,503 | 4,980 | 4,695 | 4,428 | 7,367 | 5,995 | 4,510 | 4,493 | 5,141 | 4,763 |
| Other Income - | 57.00 | 93.00 | 51.00 | 11.00 | 29.00 | 258.00 | 36.00 | 40.00 | 25.00 | 13.00 | 108.00 | 33.00 |
| Exceptional Items | 360.00 | -169.00 | -60.00 | -3.00 | 234.00 | -33.00 | -285.00 | -4.00 | -6.00 | -9.00 | -22.00 | -207.00 |
| Depreciation | 369.00 | 382.00 | 554.00 | 382.00 | 349.00 | 340.00 | 371.00 | 415.00 | 291.00 | 347.00 | 288.00 | 281.00 |
| Profit Before Tax | 981.00 | 170.00 | 28.00 | 630.00 | 1,133 | 1,233 | 904.00 | 859.00 | 738.00 | 542.00 | 40.00 | 207.00 |
| Tax % | 14.78 | 57.06 | 332.14 | 34.44 | 26.21 | 27.17 | 36.17 | 26.19 | 22.09 | 28.60 | 200.00 | 33.33 |
| Net Profit - | 836.00 | 73.00 | -65.00 | 413.00 | 836.00 | 898.00 | 577.00 | 634.00 | 575.00 | 387.00 | -40.00 | 138.00 |
| Minority Share | 3.00 | 4.00 | 4.00 | 1.00 | - | - | -3.00 | 8.00 | 1.00 | 5.00 | -18.00 | -29.00 |
| Exceptional Items At | 281.00 | 32.00 | 328.00 | -2.00 | -21.00 | -24.00 | -165.00 | -3.00 | -4.00 | -6.00 | 23.00 | -93.00 |
| Profit For PE | 555.00 | 41.00 | -369.00 | 415.00 | 856.00 | 922.00 | 739.00 | 637.00 | 579.00 | 393.00 | -63.00 | 182.00 |
| Profit For EPS | 839.00 | 77.00 | -61.00 | 414.00 | 836.00 | 898.00 | 574.00 | 643.00 | 576.00 | 392.00 | -58.00 | 109.00 |
| EPS In Rs | 52.69 | 4.84 | -3.83 | 25.98 | 52.47 | 56.39 | 36.06 | 40.35 | 36.14 | 24.60 | -3.63 | 6.84 |
| Dividend Payout % | 9.00 | 102.00 | -130.00 | 19.00 | 10.00 | 9.00 | 12.00 | 7.00 | 8.00 | 12.00 | -83.00 | 43.00 |
| PAT Margin % | 11.56 | 1.09 | -1.03 | 6.74 | 13.71 | 15.03 | 6.33 | 8.43 | 9.81 | 6.73 | -0.70 | 2.40 |
| PBT Margin | 13.56 | 2.54 | 0.45 | 10.28 | 18.58 | 20.63 | 9.92 | 11.43 | 12.59 | 9.43 | 0.70 | 3.59 |
| Tax | 145.00 | 97.00 | 93.00 | 217.00 | 297.00 | 335.00 | 327.00 | 225.00 | 163.00 | 155.00 | 80.00 | 69.00 |
| Adj Ebit | 861.00 | 612.00 | 276.00 | 779.00 | 1,084 | 1,466 | 1,409 | 1,148 | 1,085 | 922.00 | 430.00 | 751.00 |
| Adj EBITDA | 1,230 | 994.00 | 830.00 | 1,161 | 1,433 | 1,806 | 1,780 | 1,563 | 1,376 | 1,269 | 718.00 | 1,032 |
| Adj EBITDA Margin | 17.00 | 14.83 | 13.21 | 18.94 | 23.50 | 30.22 | 19.54 | 20.79 | 23.48 | 22.07 | 12.48 | 17.91 |
| Adj Ebit Margin | 11.90 | 9.13 | 4.39 | 12.71 | 17.77 | 24.53 | 15.46 | 15.27 | 18.51 | 16.04 | 7.48 | 13.03 |
| Adj PAT | 1,143 | 0.43 | 74.28 | 411.03 | 1,009 | 873.97 | 395.08 | 631.05 | 570.33 | 380.57 | -18.00 | -0.01 |
| Adj PAT Margin | 15.80 | 0.01 | 1.18 | 6.71 | 16.54 | 14.62 | 4.34 | 8.39 | 9.73 | 6.62 | -0.31 | - |
| Ebit | 501.00 | 781.00 | 336.00 | 782.00 | 850.00 | 1,499 | 1,694 | 1,152 | 1,091 | 931.00 | 452.00 | 958.00 |
| EBITDA | 870.00 | 1,163 | 890.00 | 1,164 | 1,199 | 1,839 | 2,065 | 1,567 | 1,382 | 1,278 | 740.00 | 1,239 |
| EBITDA Margin | 12.03 | 17.35 | 14.17 | 18.99 | 19.66 | 30.77 | 22.66 | 20.84 | 23.58 | 22.23 | 12.87 | 21.50 |
| Ebit Margin | 6.93 | 11.65 | 5.35 | 12.76 | 13.94 | 25.08 | 18.59 | 15.32 | 18.61 | 16.19 | 7.86 | 16.63 |
| NOPAT | 685.17 | 222.86 | -522.31 | 503.50 | 778.48 | 879.79 | 876.39 | 817.81 | 825.85 | 649.03 | -322.00 | 478.69 |
| NOPAT Margin | 9.47 | 3.32 | -8.31 | 8.21 | 12.76 | 14.72 | 9.62 | 10.88 | 14.09 | 11.29 | -5.60 | 8.31 |
| Operating Profit | 804.00 | 519.00 | 225.00 | 768.00 | 1,055 | 1,208 | 1,373 | 1,108 | 1,060 | 909.00 | 322.00 | 718.00 |
| Operating Profit Margin | 11.11 | 7.74 | 3.58 | 12.53 | 17.30 | 20.21 | 15.07 | 14.74 | 18.09 | 15.81 | 5.60 | 12.46 |
🏦 Balance Sheet
| Metric | Mar 2025 | Sep 2024 | Mar 2024 | Sep 2023 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | - | - | 2,720 | - | 2,185 | 1,821 | 1,481 | 1,643 | 1,257 | 888.00 |
| Advance From Customers | - | - | - | - | - | - | - | - | - | - |
| Average Capital Employed | 9,028 | 9,038 | 9,078 | - | 8,789 | 8,040 | 8,992 | 10,031 | 8,577 | 7,470 |
| Average Invested Capital | 7,852 | 8,300 | 8,256 | - | 8,358 | 7,730 | 8,743 | 9,730 | 8,752 | 7,990 |
| Average Total Assets | 12,047 | 11,662 | 11,134 | - | 10,380 | 9,296 | 10,536 | 11,814 | 10,388 | 9,178 |
| Average Total Equity | 5,830 | 5,664 | 5,406 | - | 5,354 | 5,030 | 5,173 | 5,206 | 4,422 | 3,712 |
| Cwip | 2,715 | 1,857 | 2,103 | 1,095 | 1,562 | 1,090 | 897.00 | 768.00 | 901.00 | 671.00 |
| Capital Employed | 8,969 | 9,007 | 9,086 | 9,070 | 9,069 | 8,509 | 7,571 | 10,412 | 9,650 | 7,504 |
| Cash Equivalents | 1,089 | 1,077 | 957.00 | 974.00 | 1,014 | 984.00 | 671.00 | 1,400 | 1,370 | 249.00 |
| Fixed Assets | 6,091 | 5,962 | 5,091 | 5,989 | 5,183 | 4,871 | 4,609 | 6,340 | 5,648 | 5,401 |
| Gross Block | - | - | 7,811 | - | 7,368 | 6,692 | 6,090 | 7,983 | 6,906 | 6,289 |
| Inventory | 1,129 | 1,162 | 1,290 | 1,328 | 1,380 | 1,255 | 1,129 | 1,845 | 1,417 | 1,391 |
| Invested Capital | 7,810 | 7,866 | 7,895 | 8,734 | 8,616 | 8,100 | 7,360 | 10,126 | 9,334 | 8,169 |
| Investments | 44.00 | 42.00 | 42.00 | 266.00 | 256.00 | 239.00 | 241.00 | 69.00 | 115.00 | 124.00 |
| Lease Liabilities | 294.00 | 255.00 | 250.00 | 248.00 | 267.00 | 264.00 | 246.00 | 180.00 | - | - |
| Loans N Advances | 28.00 | 22.00 | 193.00 | - | 159.00 | 125.00 | 126.00 | 119.00 | 111.00 | 101.00 |
| Long Term Borrowings | 2,150 | 2,542 | 3,167 | 3,170 | 3,110 | 2,464 | 2,564 | 3,740 | 4,243 | 3,048 |
| Net Debt | 1,598 | 1,961 | 2,665 | 2,428 | 2,407 | 1,969 | 1,918 | 3,339 | 3,355 | 3,096 |
| Net Working Capital | -996.00 | 47.00 | 701.00 | 1,650 | 1,871 | 2,139 | 1,854 | 3,018 | 2,785 | 2,097 |
| Non Controlling Interest | -16.00 | -14.00 | -13.00 | -9.00 | -8.00 | -2.00 | - | - | - | -52.00 |
| Other Asset Items | 770.00 | 1,007 | 746.00 | 843.00 | 413.00 | 339.00 | 270.00 | 475.00 | 484.00 | 390.00 |
| Other Borrowings | - | - | - | - | - | - | - | 239.00 | 98.00 | 176.00 |
| Other Liability Items | 2,782 | 2,091 | 1,396 | 1,406 | 1,039 | 753.00 | 672.00 | 808.00 | 649.00 | 817.00 |
| Reserves | 6,239 | 5,925 | 5,418 | 5,394 | 5,383 | 5,303 | 4,726 | 5,588 | 4,793 | 4,071 |
| Share Capital | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 |
| Short Term Borrowings | 287.00 | 283.00 | 247.00 | 250.00 | 300.00 | 463.00 | 20.00 | 650.00 | 500.00 | 245.00 |
| Short Term Loans And Advances | - | - | 1.00 | 1.00 | 16.00 | 10.00 | 7.00 | 10.00 | 9.00 | 7.00 |
| Total Assets | 12,756 | 11,924 | 11,338 | 11,400 | 10,929 | 9,830 | 8,763 | 12,310 | 11,319 | 9,457 |
| Total Borrowings | 2,731 | 3,080 | 3,664 | 3,668 | 3,677 | 3,192 | 2,830 | 4,808 | 4,840 | 3,469 |
| Total Equity | 6,239 | 5,927 | 5,421 | 5,401 | 5,391 | 5,317 | 4,742 | 5,604 | 4,809 | 4,035 |
| Total Equity And Liabilities | 12,756 | 11,924 | 11,338 | 11,400 | 10,929 | 9,830 | 8,763 | 12,310 | 11,319 | 9,457 |
| Total Liabilities | 6,517 | 5,997 | 5,917 | 5,999 | 5,538 | 4,513 | 4,021 | 6,706 | 6,510 | 5,422 |
| Trade Payables | 1,005 | 826.00 | 856.00 | 924.00 | 821.00 | 568.00 | 520.00 | 1,090 | 1,020 | 1,136 |
| Trade Receivables | 892.00 | 795.00 | 916.00 | 1,808 | 1,922 | 1,856 | 1,640 | 2,586 | 2,544 | 2,262 |
💵 Cash Flows
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash From Financing Activity | -1,453 | -432.00 | -157.00 | -33.00 | -1,709 | -1,050 | 657.00 | -901.00 |
| Cash From Investing Activity | 488.00 | -596.00 | -474.00 | -323.00 | -727.00 | -267.00 | -1,018 | -614.00 |
| Cash From Operating Activity | 1,072 | 971.00 | 661.00 | 838.00 | 1,784 | 1,543 | 1,122 | 1,303 |
| Cash Paid For Acquisition Of Companies | - | - | - | - | - | - | - | - |
| Cash Paid For Investment In Subsidaries And Associates | -1.00 | - | - | - | - | - | - | - |
| Cash Paid For Purchase Of Fixed Assets | -1,116 | -898.00 | -814.00 | -600.00 | -527.00 | -574.00 | -656.00 | -489.00 |
| Cash Paid For Purchase Of Investments | - | -8.00 | -13.00 | -2.00 | -202.00 | -4.00 | - | -20.00 |
| Cash Paid For Redemption Of Debentures | - | - | - | - | - | - | - | - |
| Cash Paid For Repayment Of Borrowings | -1,100 | -138.00 | -2,773 | -5.00 | -2,580 | -1,610 | -1,313 | -628.00 |
| Cash Received From Borrowings | 27.00 | 117.00 | 3,005 | 247.00 | 1,230 | 1,112 | 1,974 | - |
| Cash Received From Issue Of Shares | 1.00 | - | - | - | - | - | 266.00 | 1.00 |
| Cash Received From Sale Of Fixed Assets | 5.00 | 10.00 | 19.00 | 4.00 | 13.00 | 7.00 | 8.00 | 5.00 |
| Cash Received From Sale Of Investments | 952.00 | 236.00 | 245.00 | 44.00 | - | 24.00 | - | 8.00 |
| Change In Inventory | 78.00 | 91.00 | -65.00 | -96.00 | 134.00 | -374.00 | 17.00 | -135.00 |
| Change In Other Working Capital Items | -46.00 | 90.00 | -130.00 | -11.00 | - | - | - | - |
| Change In Payables | 55.00 | 23.00 | 210.00 | - | 228.00 | -25.00 | -112.00 | 289.00 |
| Change In Receivables | 24.00 | 49.00 | 39.00 | -72.00 | -113.00 | 220.00 | -205.00 | -140.00 |
| Change In Working Capital | 112.00 | 253.00 | 54.00 | -178.00 | 250.00 | -180.00 | -301.00 | 14.00 |
| Direct Taxes Paid | -238.00 | -208.00 | -204.00 | -194.00 | -394.00 | -249.00 | -343.00 | -258.00 |
| Dividends Paid | -80.00 | -80.00 | -80.00 | -80.00 | -1.00 | -153.00 | -55.00 | -56.00 |
| Dividends Received | - | 27.00 | 9.00 | - | - | - | - | - |
| Interest Paid | -236.00 | -244.00 | -234.00 | -135.00 | -292.00 | -325.00 | -215.00 | -218.00 |
| Interest Received | 38.00 | 26.00 | 10.00 | 4.00 | 4.00 | 25.00 | 9.00 | 9.00 |
| Net Cash Flow | 107.00 | -58.00 | 30.00 | 482.00 | -652.00 | 225.00 | 761.00 | -212.00 |
| Other Cash Financing Items Paid | -66.00 | -88.00 | -74.00 | -60.00 | -66.00 | -74.00 | - | - |
| Other Cash Investing Items Paid | 609.00 | 11.00 | 70.00 | 228.00 | -14.00 | 256.00 | -378.00 | -128.00 |
| Profit From Operations | 1,199 | 926.00 | 811.00 | 1,210 | 1,928 | 1,971 | 1,765 | 1,547 |
🧾 Shareholding Pattern
| Nse Code | Date | Promoters | Fii | Dii | Public | Others |
|---|---|---|---|---|---|---|
| Jublpharma | 2025-03-31 | - | 17.23 | 7.05 | 24.48 | 0.56 |
| Jublpharma | 2024-12-31 | - | 16.96 | 6.99 | 24.82 | 0.56 |
| Jublpharma | 2024-09-30 | - | 17.94 | 5.66 | 25.17 | 0.56 |
| Jublpharma | 2024-06-30 | - | 19.50 | 4.06 | 25.18 | 0.58 |
💬
Stock Chat